Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Microchip Separates White Blood Cells from Whole Blood

By LabMedica International staff writers
Posted on 14 Aug 2013
A new microchip can quickly separate white blood cells from samples of whole blood, eliminating any preliminary processing steps, which could make it difficult to integrate into point-of-care medical devices.

The scientists aim is to integrate the microchip into a portable diagnostic device that may be used to directly analyze patient blood samples for signs of inflammatory disease such as sepsis—particularly in regions of developing countries where diagnostic lab equipment is not readily available. More...


The scientists pumped tiny volumes of blood through the microchip and recovered a highly pure stream of white blood cells, virtually devoid of other blood components such as platelets and red blood cells. The team found that the sorted cells were undamaged and functional, potentially enabling clinicians not only to obtain a white blood cell count, but also to use the cells to perform further genetic or clinical tests.

The chip works by mimicking the physiological process of “cell rolling” where patterns of adhesive molecules are used to draw out neutrophils from a stream of blood into a parallel buffer stream. For blood samples, Prof. Karnik, Rohit Karnik, an associate professor of mechanical engineering at Massachusetts Institute of Technology (MIT; Cambridge, MA, USA) and Suman Bose worked in parallel on a new microchip design. The team etched a pattern of microscopically thin gold stripes, diagonal to the flow of fluid through the chip. They then attached molecules of P-selectin along each gold stripe. Before flowing blood through the chip, the team tested the design with a culture of two types of leukemia cells. Through video imaging, they observed that one cell type was drawn out of the stream, attaching and rolling briefly along a sticky gold stripe before jumping to a neighboring line. Eventually, after a series of jumps and rolls, the cells rolled the rest of the way along a stripe, then into a separate gutter, or channel, where they flowed into a collector.

Rohit Karnik, an associate professor of mechanical engineering at MIT, said that the key to recovering such pure, functional cells lies in the microchip’s adaption of the body’s natural process of cell rolling.

“We believe that because we’re using a very biomimetic process, the cells are happier,” said Prof. Karnik an associate professor of mechanical engineering at MIT, “It’s a more gentle process, and the cells are functionally viable.” Prof. Karnik and colleagues published their results in the July 2013 issue of the journal Scientific Reports.

Related Links:
Massachusetts Institute of Technology



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Pipette Calibration System
Artel PCS®
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.